Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
Src and signaling molecules downstream of Src, including signal transducer and activator of transcription 3 (Stat3) and cMyc, have been implicated in the development, maintenance and/or progression of several types of human cancers, including breast cancer. Here we report the ability of siRNA-mediat...
Main Authors: | Jeffrey D Bjorge, Andy S Pang, Melanie Funnell, Ke Yun Chen, Roman Diaz, Anthony M Magliocco, Donald J Fujita |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-04-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3082570?pdf=render |
Similar Items
-
Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release.
by: Jeffrey D Bjorge, et al.
Published: (2017-01-01) -
Src regulates the activity of the ING1 tumor suppressor.
by: Lisa Yu, et al.
Published: (2013-01-01) -
Therapeutic siRNAs: small molecules with bigger function
by: Ruby Dhar, et al.
Published: (2024-01-01) -
Imaging small molecule-induced endosomal escape of siRNA
by: Hampus Du Rietz, et al.
Published: (2020-04-01) -
Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
by: Yen-Dun Tony Tzeng, et al.
Published: (2018-11-01)